Optiscan Imaging Osake

Optiscan Imaging PEG

PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Optiscan Imaging (OIL.AX) 23.6.2026 päivämäärällä on −9,97.

PEG

−9,97

Viimeksi päivitetty:

PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Optiscan Imaging on 2026 −9,97 . PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Optiscan Imaging oli 2025 0 . Se laskee % matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Optiscan Imaging Osakeanalyysi

Mitä Optiscan Imaging tekee? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Optiscan Imaging osakkeesta

PEG-suhde (Hinta-tuotto-kasvu-suhde) oli Optiscan Imaging 0 −9,97

Access this data via the Eulerpool API

Arvostus — Optiscan Imaging

Kaikki tunnusluvut — Optiscan Imaging